Prostatic Urethral Lift/UroLift for Benign Prostatic Hyperplasia
Customize your policy alerts
Sign up for AmeriHealth Caritas Policy CCP.1529 alerts
Get alerted when Policy CCP.1529 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage determinations for prostatic urethral lift (UroLift) to treat lower urinary tract symptoms due to benign prostatic hyperplasia. Coverage may be medically necessary when specified prostate-volume and anatomy criteria are met, with case-by-case consideration for selected patients outside the standard criteria.
In 2025, the medical necessity criteria were revised to align with current American Urological Association recommendations by deleting the age criterion and the requirement for medication failure.
In 2026, the policy references were updated and the coverage section was identified as modified, although the policy states that no major policy changes were warranted.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.